 Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector 
              "Markets will keep a constant watch over remaining set of quarterly numbers and further movement is expected to be largely stock specific depending upon results meeting expectations or any important news flow. Domestically, GST impact is being felt on most of the manufacturers and is likely to persist till Q2FY18 before the benefits of the shift from unorganized to organized start flowing in. Ironing out of issues related to e-way bill is likely to be closely watched out for.
Globally the focus will be on non-farm payrolls data to gauge the chances of further rate hikes by US Fed. Any indications on liquidity tightening from global banks is likely to impact markets negatively as markets are currently trading at fair valuations".